Misonix Strengthens Presence in European Cancer Treatment Market by Acquiring Controlling Interest in UK-HIFU
19th Apr 2006, 20:46 GMT
Misonix, a developer of ultrasonic medical device technology for the treatment of cancer and other health conditions, announced that it's acquired a controlling interest in its UK distributor, UK-HIFU as a part of its strategic commitment to expand its high intensity focused ultrasound operations in Europe.
Misonix Strengthens Presence in European Cancer Treatment Market by Acquiring Controlling Interest in UK-HIFU related news:
- EDAP TMS SA Reports Success, Rapidly Growing Interest at EAU Congress — Ultrasound News from StratCenter.com
- China Medical Technologies Sponsors the 1st HIFU Project Initiated by the PRC Ministry of Health and Completes the Development of Its 3rd Generation HIFU Therapy System — Executive Announcements News from StratCenter.com
- Market report: Friday close — This is Money | News
- Market report: Friday 14.30 — This is Money | Investing & markets
- Fundamental change in cancer treatment — The Cancer Blog
- Preserving Fertility in Cancer Patients is an Important Pre-Treatment Step — PR Web (The Free Wire Service) Medical
- Biofield Undergoes a Change in Control; The MacKay Group Acquires Controlling Interest and appoints President and Board — Intensive/ Critical Care News from StratCenter.com
- Gene Profile To Help Decide On Breast Cancer Treatment — Medical News Today RSS/XML Feed
- Burns winning his cancer battle — BBC Sport | Football | Scottish Premier | UK Edition
- Cancer test to determine best cancer treatment — The Cancer Blog